InsiderClue
← All stocks

Biohaven Ltd.

BHVN Net buying
CIK 0001935979 #2019 in the set updated 17 Sep 2026
Bought (12 mo)
$33.14M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$33.14M
+$33.14M against sales at will

By person

8 insiders · 5 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
CHILDS JOHN W
Director
$25.00M (1)
—
+$25.00M
5,653,904
3.74%
$48.15M
+152.7%
Coric Vlad
Chief Executive Officer
$5.00M (2)
—
+$5.00M
2,544,514
1.68%
$21.67M
+38.1%
Bailey Gregory
Director
$3.00M (1)
—
+$3.00M
2,020,071
1.34%
$17.20M
+25.1%
Clark George C.
VP, Chief Accounting Officer
$144.77K (1)
—
+$144.77K
86,978
0.0576%
$740.70K
+29.4%
Buten Matthew
Chief Financial Officer
—
—
—
195,652
0.1295%
$1.67M
+1.7%
Gentile Kimberly
SVP, Clinical Operations
—
—
—
99,557
0.0659%
$847.82K
+3.7%
Mehta Kishan
Director
—
—
—
22,662
0.0150%
$192.99K
0.0%
Car Bruce
Chief Scientific Officer
—
—
—
7,715
0.0051%
$65.70K
+163.6%

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
Clark George C.
17 Nov 2025
VP, Chief Accounting Officer
Buy indirect
17,000
$8.52
$144.77K
Coric Vlad
13 Nov 2025
Chief Executive Officer
Buy indirect
333,333
$7.50
$2.50M
Coric Vlad
13 Nov 2025
Chief Executive Officer
Buy indirect
333,333
$7.50
$2.50M
CHILDS JOHN W
13 Nov 2025
Director
Buy indirect
3,333,333
$7.50
$25.00M
Bailey Gregory
13 Nov 2025
Director
Buy
400,000
$7.50
$3.00M

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 79,662
History held since 5 Oct 2022